Overview

Study of T3 for the Treatment of Fibromyalgia

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Determine if T3 - the active form of thyroid hormone - is beneficial in fibromyalgia. Determine the feasibility and promise of an appropriately powered future prospective randomized controlled study of using T3 (the active form of thyroid hormone) for the treatment of fibromyalgia. We specifically aim to assess the feasibility, cost, obstacles and promise of conducting a prospective controlled study in the future.
Phase:
N/A
Details
Lead Sponsor:
Stanford University